Aeglea BioTherapeutics Inc. (AGLE) declined -15.46% or -1.69 to $9.24. It is near 1.01 million shares traded, which is 687.86% compare to the average total volume 146850. The market cap of AGLE is $203.23 million. The year to date change is 87.7%. The 52 week price range is from $3.75 to $12.0. Price of AGLE have changed 3.70% during last week. It have changed 16.52% over last month, 6.43% over last 3 months, 72.13% over last 6 months N/A
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 9.68. It is 4.76% above current price. The 200-day Moving Averages for AGLE is 8.18. It is -11.47% below current price. The 52-week High is 12.0. It is 29.87% from the current price. The 52-week Low is 3.75. It is -59.42% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 3.45 on 2018-08-15. Short % to float is 2.33%. There are some statistics of AGLE. It is has market cap $203.23 million. The share outstanding is 22.00 million. The average volume is 146850. The revenue is 1.26M. The percent of top 15 Institution holding is 62.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -46.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -43.43%.